Halma PLC Annual Financial Report

RNS Number : 6641T

Halma PLC

24 June 2024

 

Halma plc

 

Annual Report and Accounts 2024 and Notice of Annual General Meeting

 

Halma announces that the Annual Report and Accounts 2024 and the Notice of Meeting have been posted to shareholders (where applicable) and, in accordance with Disclosure Guidance and Transparency Rule 6.3.5(3)R, are available to view on the Company's website at www.halma.com. 

 

Copies of these documents and the Proxy Form have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

The Full Year Results, containing information required under Disclosure Guidance and Transparency Rule 6.3.5R were released on 13 June 2024 and are also available on the Company's website.

 

For further information, please contact:
Mark Jenkins Company Secretary, Halma plc Tel: [phone]

 

NOTE TO EDITORS

 

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
·      Safety	Protecting people's safety and the environment as populations grow, and enhancing worker safety.
·      Environment	Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
·      Health	Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

 

Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.   Halma has been named as one of Britain's Most Admired Companies for the past six years.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

ACSQKQBBABKDQAB